Ginkgo Biloba: The World’s Oldest Living Tree and One of the Most Researched Brain Herbs
Ginkgo biloba is one of the oldest living tree species on Earth — a living fossil that survived the last ice age and has been used in traditional Chinese medicine for over 4,000 years. Its seeds and leaves have been prescribed for respiratory conditions, circulatory disorders, and cognitive decline for millennia, and modern research has validated many of these traditional uses, particularly for cerebral circulation and cognitive function. What makes ginkgo interesting from a mechanism perspective is its multi-target action: it improves blood flow (particularly in the brain), acts as an antioxidant, modulates neurotransmitter systems, and reduces neuroinflammation. For a single herb, that’s an unusually comprehensive profile of actions relevant to brain health.
The primary mechanism of ginkgo involves the improvement of cerebral blood flow — and this is particularly relevant because adequate blood flow to the brain is one of the most important (and most overlooked) determinants of cognitive function. The brain uses roughly 20% of the body’s oxygen and energy despite being only 2% of body weight, and it depends entirely on a continuous supply of blood to deliver oxygen and glucose. When cerebral blood flow is reduced (as it often is with aging, atherosclerosis, or simply being sedentary), cognitive function suffers. Ginkgo improves cerebral circulation through multiple mechanisms: it dilates blood vessels, reduces blood viscosity (making blood flow more easily), and protects the endothelial lining of blood vessels from oxidative damage.
Memory and Cognitive Function Research
The research on ginkgo for cognitive function is extensive but mixed, which is typical for complex herbal extracts. Some studies show meaningful benefits in age-related cognitive decline and early-stage dementia; others show minimal effects. The most consistent finding is that ginkgo improves cognitive performance in people with cognitive impairment — particularly those with cerebrovascular insufficiency (reduced blood flow to the brain). For healthy younger people, the cognitive enhancement effects are less pronounced, though some studies show improvements in attention, memory, and processing speed.
A large-scale trial called the GEM study (Ginkgo Evaluation of Memory) enrolled over 3,000 participants over the age of 75 and found no benefit for ginkgo in preventing dementia or cognitive decline. However, this study has been criticised for methodological issues — particularly that the study population included people with existing cognitive impairment, which may have diluted the effect in those who might have benefited most. The consensus among integrative practitioners is that ginkgo works best for people with age-related cognitive decline who have measurable reductions in cerebral blood flow, and that quality and dose matter enormously.
Forms, Dosing, and Quality
The active compounds in ginkgo are flavonoids (ginkgolides, bilobalide) and the standardised extract typically contains 24% flavonoids and 6% terpene lactones. This is the form used in virtually all the clinical research. Doses in studies range from 120–240mg daily, divided into two or three doses. Lower doses (60–120mg) are used for general cognitive maintenance. The important caveat: ginkgo should only be used with an extract standardised to contain less than 5ppm of ginkgolic acid (which can be toxic in high amounts), and should not be combined with blood-thinning medications (warfarin, aspirin, clopidogrel) without medical supervision due to its mild antiplatelet effects.
Key Takeaways
Ginkgo biloba is one of the most researched herbs for brain circulation and cognitive function, with evidence supporting its use in age-related cognitive decline and cerebrovascular insufficiency. Works by improving cerebral blood flow, reducing blood viscosity, and providing antioxidant protection. Effective doses are 120–240mg daily of standardised extract (24% flavonoids, 6% terpene lactones, <5ppm ginkgolic acid). Not for use with blood thinners. Quality matters enormously — use pharmaceutical-grade extract.
Iron Role in Brain Energy Metabolism
Iron is essential for brain function far beyond its role in haemoglobin and oxygen transport. The brain consumes approximately 20% of the body oxygen despite accounting for only 2% of body weight, and iron is critical in this energy metabolism — particularly in the electron transport chain within mitochondria, where iron-sulfur clusters are essential components of Complexes I, II, and III. Iron is also a cofactor for tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis, and for ribonucleotide reductase, the enzyme required for DNA synthesis. These roles mean that iron deficiency — even without frank anaemia — can impair dopaminergic signalling, reduce neural energy production, and compromise myelin formation, with measurable effects on attention, memory, and executive function.
Why Iron Deficiency Is So Common
Iron deficiency is the most common nutritional deficiency worldwide, affecting an estimated 2 billion people. In menstruating women, iron deficiency is particularly prevalent due to monthly menstrual blood loss — even a “normal” menstrual iron loss of 30-40ml per cycle can gradually deplete iron stores over months to years. In men and post-menopausal women, iron deficiency should always be investigated as it can signal occult gastrointestinal blood loss. The symptoms of iron deficiency extend well beyond fatigue and pallor: restless legs syndrome (strongly associated with brain iron deficiency), impaired thermoregulation, reduced exercise tolerance, and cognitive impairment in both children and adults.
Iron Status: Not Just Haemoglobin
The standard diagnostic marker for iron deficiency is haemoglobin — but this misses the majority of iron-deficient people, because haemoglobin only falls after iron stores (ferritin) are already significantly depleted. Ferritin is the storage form of iron, and a level below 30 ng/mL indicates depleted stores, while anything below 15 ng/mL indicates frank deficiency. Optimal ferritin for cognitive function appears to be in the range of 50-100 ng/mL. Iron supplementation should always be guided by ferritin testing, not haemoglobin alone, and excessive iron (from over-supplementation or haemochromatosis) carries its own serious risks including liver cirrhosis and increased infection risk through iron-dependent pathogen growth.
Leave a Reply